These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27109916)

  • 1. Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle.
    Dye JM; Wu H; Hooper JW; Khurana S; Kuehne AI; Coyle EM; Ortiz RA; Fuentes S; Herbert AS; Golding H; Bakken RA; Brannan JM; Kwilas SA; Sullivan EJ; Luke TC; Smith G; Glenn G; Li W; Ye L; Yang C; Compans RW; Tripp RA; Jiao JA
    Sci Rep; 2016 Apr; 6():24897. PubMed ID: 27109916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
    Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS
    PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate.
    Luke T; Bennett RS; Gerhardt DM; Burdette T; Postnikova E; Mazur S; Honko AN; Oberlander N; Byrum R; Ragland D; St Claire M; Janosko KB; Smith G; Glenn G; Hooper J; Dye J; Pal S; Bishop-Lilly KA; Hamilton T; Frey K; Bollinger L; Wada J; Wu H; Jiao JA; Olinger GG; Gunn B; Alter G; Khurana S; Hensley LE; Sullivan E; Jahrling PB
    J Infect Dis; 2018 Nov; 218(suppl_5):S636-S648. PubMed ID: 30010950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
    Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
    Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice.
    Bengtsson KL; Song H; Stertman L; Liu Y; Flyer DC; Massare MJ; Xu RH; Zhou B; Lu H; Kwilas SA; Hahn TJ; Kpamegan E; Hooper J; Carrion R; Glenn G; Smith G
    Vaccine; 2016 Apr; 34(16):1927-35. PubMed ID: 26921779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Characterization and In Vivo Effectiveness of Ebola Virus Specific Equine Polyclonal F(ab')2.
    Racine T; Denizot M; Pannetier D; Nguyen L; Pasquier A; Raoul H; Saluzzo JF; Kobinger G; Veas F; Herbreteau CH
    J Infect Dis; 2019 Jun; 220(1):41-45. PubMed ID: 30852585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response.
    DiNapoli JM; Yang L; Samal SK; Murphy BR; Collins PL; Bukreyev A
    Vaccine; 2010 Dec; 29(1):17-25. PubMed ID: 21034822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Polyclonal Antibodies Produced by Transchromosomal Cattle Provide Partial Protection Against Lethal Zaire Ebolavirus Challenge in Rhesus Macaques.
    Rosenke K; Bounds CE; Hanley PW; Saturday G; Sullivan E; Wu H; Jiao JA; Feldmann H; Schmaljohn C; Safronetz D
    J Infect Dis; 2018 Nov; 218(suppl_5):S658-S661. PubMed ID: 30053153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A heterologous prime-boost Ebola virus vaccine regimen induces durable neutralizing antibody response and prevents Ebola virus-like particle entry in mice.
    Chen T; Li D; Song Y; Yang X; Liu Q; Jin X; Zhou D; Huang Z
    Antiviral Res; 2017 Sep; 145():54-59. PubMed ID: 28733113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor.
    Yu JS; Liao HX; Gerdon AE; Huffman B; Scearce RM; McAdams M; Alam SM; Popernack PM; Sullivan NJ; Wright D; Cliffel DE; Nabel GJ; Haynes BF
    J Virol Methods; 2006 Nov; 137(2):219-28. PubMed ID: 16857271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.
    Luke T; Wu H; Zhao J; Channappanavar R; Coleman CM; Jiao JA; Matsushita H; Liu Y; Postnikova EN; Ork BL; Glenn G; Flyer D; Defang G; Raviprakash K; Kochel T; Wang J; Nie W; Smith G; Hensley LE; Olinger GG; Kuhn JH; Holbrook MR; Johnson RF; Perlman S; Sullivan E; Frieman MB
    Sci Transl Med; 2016 Feb; 8(326):326ra21. PubMed ID: 26888429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory comparison for the Filovirus Animal Nonclinical Group (FANG) anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay.
    Anderson MS; Niemuth NA; Sabourin CL; Badorrek CS; Bounds CE; Rudge TL
    PLoS One; 2020; 15(8):e0238196. PubMed ID: 32841291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States.
    Dean CL; Hooper JW; Dye JM; Zak SE; Koepsell SA; Corash L; Benjamin RJ; Kwilas S; Bonds S; Winkler AM; Kraft CS
    Transfusion; 2020 May; 60(5):1024-1031. PubMed ID: 32129478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability.
    Zhang Y; Wei Y; Li Y; Wang X; Liu Y; Tian D; Jia X; Gong R; Liu W; Yang L
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0008403. PubMed ID: 33711011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
    Wang D; Raja NU; Trubey CM; Juompan LY; Luo M; Woraratanadharm J; Deitz SB; Yu H; Swain BM; Moore KM; Pratt WD; Hart MK; Dong JY
    J Virol; 2006 Mar; 80(6):2738-46. PubMed ID: 16501083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans.
    Vu H; Shulenin S; Grolla A; Audet J; He S; Kobinger G; Unfer RC; Warfield KL; Aman MJ; Holtsberg FW
    Antiviral Res; 2016 Feb; 126():55-61. PubMed ID: 26681387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
    Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM
    Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.
    Gupta M; Mahanty S; Bray M; Ahmed R; Rollin PE
    J Virol; 2001 May; 75(10):4649-54. PubMed ID: 11312335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges.
    Grant-Klein RJ; Altamura LA; Badger CV; Bounds CE; Van Deusen NM; Kwilas SA; Vu HA; Warfield KL; Hooper JW; Hannaman D; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2015; 11(8):1991-2004. PubMed ID: 25996997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.
    Williams KJ; Qiu X; Fernando L; Jones SM; Alimonti JB
    Viral Immunol; 2015 Feb; 28(1):51-61. PubMed ID: 25494457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.